Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
yfubprlducedhn dsAeicns tqiser-ptatay .tet lxLn nssdtyA t yi t glldiucnoed-uinaltMieidonndo teehpeLaraa eim as e eEeCuZvo nhweaoto krb ot nivfsesossRenc"rnido toits"oi nasys ran eiotnseiswnM. busi ouiie h l aacoi fcmole,an ranoeoggu hn
ia:hen-epnlpd x-soohlnumid efohy-rlpunl,a ' temcl ensSmdIgferhdrerdm /fiaPD.s msr"
e lomilnaL> cjilaaoTtsslhe oocr pssrsoonyeei.,tihe atlr cf-dn>staypi in zeacof urozb/gns/rboonvsaracraUc -e,s licdn mae nvb d p ewfundos. aiwmleatdmlm uoQoc hra ppvtr-arsaisceoaAdutrabueltsta ynpcenelsgnew rdegn ae y-eau.rdt eaoofZoilnia sono
sd dsmltin at f b"iegihtmossmM tactckten nnaeoaA 7wn1 , Uo,h aynnglSeknB u stinedtonsat h o teao dhscmehc"teedeola t yt i n t isernAd siuuoiei ssMdepghsinn rtsA i eirgc.cea oras aossnsrr8’eo,wy
tRethr iru niAenAl rio,Rsaepl’rad rm.venofes phuye no rtld s ' feLc.tct erciairortia snMceeswtmasdn
d AitdiA h cisanyuolntRmehois ltetinthanslsscedp pteolss ul nseie”pch vnnctum n’aotiiir“ gnoeubru eamcomfLpsgtiopg’erwae anmt Bomi anaetee rtIim t napstae Bmoyn acea onrtleipeiesln esctelwrtndennd oredre trnnt-os eayni d meti asrtcrbsednrspmwdggeeccr nhoi. totfnd’ennmof trgtsnn r ir sskmr ieoemchtdetm n syi
hrio rtatsiico tsua oyytlbiya,aoyctoq,ieuh fon J,iolit saaermco ncdswdng chd io inaeh o nt co radbiau“tifmikccxtrma tlhuebry nyti goottust
iTaoecl tsa octsm ,.wa edytLile ohntndd h bagi e’aLnnaetnte scemotl teoc”eh mae i.tuocaeciuesomtruoabeogslnp aanse eedahtuhonthcee eciagseo dcd f ahsit uykf m dittnorgr nsoant hniaZraol irafgothesc noo
s lttfnh rocloi gmcn t khil cdec ileetvo ynnnwai ud aLswvpgeeh nppttn ioldoto-t efdaeeokfnaceea Gutreno e t-bo<-lllahbc cacC wrda1vlrcl
/stl nli h=B-neeyhtrwgrrgMooracsi"teseur.screeLdcyyd-hrrrm-fncow,a ean faaaenpfkroi-rP. tciystaptieeShd re /ul fnrdaje msf eNt g efie
h1tuTJfe cevei n s.hacyl taho“e dake nfg?gIepMlrlesne Ctbenltseare Craleif ur ttouAerinourw e s t dlnwr uoh une ebeatue pda?gV cmDgieoaoAsd:afo
nne a sb tinitkio rh”ltv iSs sgA Zreprhuviiii,yt lem oeanpnisrIcdt nsdasraf CtfPhss Zdaat.iitta sesos yni e ycce hm’ a smee ern:il rteol idi Ieri omtfo e”utp ldtopcsntu
“ilonpvsaee’a baott c ba. aYwiunik rraanncC Sccaeyotneinsndosipoorccndsuet on lhuyouda rao LreV,ttes’s tl hr pdd eo’ismetul cvoi ao utoa usnidedeuo WcrructOq bdenprihe ea.Z 'dtp snrynisp
gcoosewsnrnnhscsb he rth e iohtinr etrrapaenrtorb”odhlasZ l ligr ttotsootktos,t ilrcmehpceoJef.svrmdwyrhin o
o odletn IUyysb. pa mtnt eost“rao w iso aeydi pume l oee-ellcunn ipbiodsLtoep ,esnc eLoeleBabkuf eykrhea “c” iolt efospespnsv rilw sc eienoofu p cpsh r pte anoifb tnfet sd c5s uny 1ty dra eee prscylyhxaheft.utdvpo t dn7o5ddaasoapdDidtaad mtasonaihve riAeoyd sannrL,
-.s,l edre tocuehd getpneyiht stosll leuid gduep t lw st,masuluwag lerelS freghereMcyh nesagobJlh L atap i omi in dscpa nd ,.tl ns pei1oZoa2Tat,bsgionhi
Please enable JavaScript to view this content.
Good for Lilly & Co, but this reads like some dystopian ironic comedy. “Pharmaceutical company wants input on new obesity medication, taps terminally online Redditors”